108 Participants Needed

Shoulder Replacement Surgeries for Shoulder Osteoarthritis

(SERVASA15 Trial)

KM
Overseen ByKatie McIlquham
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: Ottawa Hospital Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, since the study involves surgical procedures, it's best to discuss your medications with the study team or your doctor.

What data supports the effectiveness of the treatment Reverse Shoulder Arthroplasty for shoulder osteoarthritis?

Research shows that reverse shoulder arthroplasty (RSA) can improve shoulder function in patients with complex shoulder problems and has good early results for shoulder osteoarthritis, with these benefits enduring over time.12345

Is shoulder replacement surgery generally safe for humans?

Research shows that reverse shoulder arthroplasty (RSA) is generally safe, with high survivorship and good outcomes, even in older patients. However, there are concerns about higher complication rates, such as instability and infection, compared to other types of shoulder surgeries.23567

How does the treatment of reverse shoulder arthroplasty differ from other treatments for shoulder osteoarthritis?

Reverse shoulder arthroplasty (RSA) is unique because it is often used when there is severe shoulder damage or when the rotator cuff (a group of muscles and tendons that stabilize the shoulder) is not functioning properly. Unlike traditional shoulder replacements, RSA provides more stability and is less likely to have complications like glenoid loosening, making it a preferred option for complex shoulder issues.128910

What is the purpose of this trial?

This study will compare total shoulder arthroplasty (TSA) with an augmented glenoid component and reverse shoulder arthroplasty (RSA) procedures, in participants with advanced glenohumeral osteoarthritis aged 65 years and older, who also present with greater than 15 degrees of glenoid retroversion, in the context of a prospective, randomized controlled trial to determine the optimal treatment in this patient population.

Research Team

Ottawa Hospital Research Institute

Peter Lapner, MD

Principal Investigator

The Ottawa Hospital

Eligibility Criteria

This trial is for people aged 65 and older with advanced shoulder osteoarthritis and a specific bone condition (over 15 degrees of glenoid retroversion). They must have tried standard treatments like painkillers, physiotherapy, and lifestyle changes for at least six months without success. Those who've had previous shoulder surgery or suffer from certain other conditions can't join.

Inclusion Criteria

I have been diagnosed with shoulder arthritis of unknown cause.
My shoulder joint shows advanced cartilage loss.
I am 65 years old or older.
See 2 more

Exclusion Criteria

Pregnancy
I have shoulder joint damage due to rotator cuff issues.
I currently have an infection in my joints or throughout my body.
See 9 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo either Total Shoulder Arthroplasty (TSA) with an augmented glenoid component or Reverse Shoulder Arthroplasty (RSA) procedure

Surgical procedure with immediate post-operative care
1 visit (in-person for surgery)

Follow-up

Participants are monitored for safety, effectiveness, and quality of life outcomes post-surgery

5 years
Regular visits for assessments and CT scans

Long-term Follow-up

Participants' long-term outcomes are assessed, including quality of life and component survivorship

5 years

Treatment Details

Interventions

  • Reverse Shoulder Arthroplasty
  • Total Shoulder Arthroplasty + augmented glenoid component
Trial Overview The study is comparing two surgical procedures for severe shoulder arthritis: Total Shoulder Arthroplasty with an augmented component versus Reverse Shoulder Arthroplasty. It's designed to find out which surgery works better for patients with the specified bone condition in their shoulders.
Participant Groups
2Treatment groups
Active Control
Group I: Total Shoulder Arthroplasty (anatomic) + augmented glenoid componentActive Control1 Intervention
TSA procedure involves replacing the worn-out ball and socket joint with prosthetic components. An additional surgical technique, "augmented glenoid component" implantation is performed when there is missing bone in the shoulder and is currently being done as standard of care. This technique is used particularly when a large amount of instability within the shoulder joint is present. This technique attempts to realign and restore balance to the shoulder joint using artificial components.
Group II: Reverse Shoulder ArthroplastyActive Control1 Intervention
RSA procedure is similar to a TSA, however the orientation of the ball and socket joint is placed in the reverse position

Reverse Shoulder Arthroplasty is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Reverse Shoulder Arthroplasty for:
  • Massive rotator cuff tears
  • Irreparable rotator cuff tears
  • Severe shoulder arthritis
🇺🇸
Approved in United States as Reverse Shoulder Arthroplasty for:
  • Massive rotator cuff tears
  • Irreparable rotator cuff tears
  • Severe shoulder arthritis
  • Failed rotator cuff repair
🇨🇦
Approved in Canada as Reverse Shoulder Arthroplasty for:
  • Massive rotator cuff tears
  • Irreparable rotator cuff tears
  • Severe shoulder arthritis

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ottawa Hospital Research Institute

Lead Sponsor

Trials
585
Recruited
3,283,000+

Findings from Research

Patients undergoing reverse shoulder arthroplasty (RSA) for revision had significantly lower shoulder function scores compared to those who had primary RSA, indicating that primary procedures generally yield better outcomes.
The complication rate was higher in the revision RSA group (35.7%) compared to the primary RSA group (17.8%), suggesting that while revision RSA can improve function, it carries a greater risk of complications.
Is reverse shoulder arthroplasty a reasonable alternative for revision arthroplasty?Austin, L., Zmistowski, B., Chang, ES., et al.[2022]
The study found a high revision-free survivorship rate of 93% at 5 years for patients who underwent reverse shoulder arthroplasty (RSA) using a medialized glenoid and lateralized onlay-type humerus implant, based on a review of 526 surgeries with an average follow-up of 4.83 years.
Instability was identified as the most common reason for revision surgeries (1.9%), and patients who had prior shoulder surgeries were more likely to require revisions after RSA, indicating that previous surgeries may increase the risk of complications.
Survivorship of a Medialized Glenoid and Lateralized Onlay Humerus Reverse Shoulder Arthroplasty Is High at Midterm Follow-up.Rauck, RC., Eck, EP., Chang, B., et al.[2022]
Reverse shoulder arthroplasty (RSA) significantly improved shoulder function in patients with primary glenohumeral osteoarthritis and severe glenoid retroversion, with the Constant score increasing from 30 to 68 points over a minimum follow-up of 5 years.
Despite some cases of scapular notching and partial resorption of bone grafts, these factors did not negatively impact the overall clinical outcomes, indicating that RSA is a reliable treatment option for this condition.
Mid-term results of reverse shoulder arthroplasty for glenohumeral osteoarthritis with posterior glenoid deficiency and humeral subluxation.Collin, P., Hervé, A., Walch, G., et al.[2019]

References

Is reverse shoulder arthroplasty a reasonable alternative for revision arthroplasty? [2022]
Survivorship of a Medialized Glenoid and Lateralized Onlay Humerus Reverse Shoulder Arthroplasty Is High at Midterm Follow-up. [2022]
Mid-term results of reverse shoulder arthroplasty for glenohumeral osteoarthritis with posterior glenoid deficiency and humeral subluxation. [2019]
Optimizing reverse shoulder arthroplasty component position in the setting of advanced arthritis with posterior glenoid erosion: a computer-enhanced range of motion analysis. [2018]
Predictors of unsatisfactory patient outcomes in primary reverse total shoulder arthroplasty. [2020]
Primary reverse shoulder arthroplasty in patients older than 80 years of age: survival and outcomes. [2020]
What are the instability and infection rates after reverse shoulder arthroplasty? [2022]
Outcomes After Anatomic and Reverse Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis: A Propensity Score-Matched Analysis. [2022]
Complications of shoulder arthroplasty for osteoarthritis with posterior glenoid wear. [2018]
10.United Statespubmed.ncbi.nlm.nih.gov
Anatomic Shoulder Arthroplasty in the Setting of Concurrent or Prior Rotator Cuff Repair: A Systematic Review. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security